- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Glembatumumab vedotin
Total 402 results
-
National Cancer Institute (NCI)CompletedRecurrent OsteosarcomaUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)CompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal MelanomaUnited States
-
Celldex TherapeuticsTerminated
-
PrECOG, LLC.Celldex TherapeuticsTerminatedStudy of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung (PrE0504)Squamous Cell Carcinoma of the LungUnited States
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
National Cancer Institute (NCI)WithdrawnMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditions
-
University of VirginiaCelldex TherapeuticsWithdrawn
-
Celldex TherapeuticsNo longer availableMetastatic gpNMB Expressing Triple Negative Breast Cancer
-
Celldex TherapeuticsCompletedBreast CancerUnited States
-
CuraGen CorporationCompletedBreast CancerUnited States
-
CuraGen CorporationCompletedUnresectable Stage III or Stage IV MelanomaUnited States
-
Chinese PLA General HospitalNot yet recruitingPD-1 Inhibitor Failed Patients With Classical Hodgkin Lymphoma
-
Merck Sharp & Dohme LLCNot yet recruitingBurkitt Lymphoma | Ewing Sarcoma | Neuroblastoma | Diffuse Large B-cell Lymphoma | B-cell Acute Lymphoblastic Leukemia
-
University of Texas Southwestern Medical CenterAstellas Pharma IncNot yet recruiting
-
RemeGen Co., Ltd.Recruiting
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingGastric Cancer/Gastroesophageal Junction Adenocarcinoma
-
Zhejiang Cancer HospitalRecruitingHER2 Gene Mutation | Bile Duct Adenocarcinoma Non-ResectableChina
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.Recruiting
-
University of Michigan Rogel Cancer CenterNot yet recruitingUrothelial CarcinomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
-
Giuseppe ProcopioNot yet recruitingCollecting Duct Carcinoma | Renal Medullary Carcinoma | Bellini CarcinomaItaly
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Wuhan Union Hospital, ChinaRecruitingGastroesophageal Junction Cancer | PD-1 | Neoadjuvant ChemoradiotherapyChina
-
Sun Yat-sen UniversityNot yet recruiting
-
RemeGen Co., Ltd.Recruiting
-
Henan Cancer HospitalNot yet recruiting
-
RemeGen Co., Ltd.RecruitingCastration-resistant Prostate CancerChina
-
RemeGen Co., Ltd.RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
Peking University First HospitalPeking University First Hospital Miyun HospitalNot yet recruiting
-
Fudan UniversityNot yet recruitingNon-muscle Invasive Bladder Cancer | HER-2 Protein Overexpression
-
University Medical Center GroningenTakedaNot yet recruitingDiffuse Large B-cell-lymphoma
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
Yan Zhang, MDPeking University First Hospital; Chinese PLA General Hospital; Peking University...Recruiting
-
RemeGen Co., Ltd.Recruiting
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States
-
RemeGen Co., Ltd.RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
RemeGen Co., Ltd.Recruiting
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Mayo ClinicRecruitingStage IV Penile Cancer AJCC v8 | Stage III Penile Cancer AJCC v8 | Metastatic Penile Squamous Cell Carcinoma | Unresectable Penile Squamous Cell CarcinomaUnited States
-
RemeGen Co., Ltd.Not yet recruiting
-
AbbVieNot yet recruiting
-
Shanghai East HospitalRecruitingGastric Cancer | HER2-low-expressing Gastric CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer HospitalRecruitingMuscle Invasive Bladder CarcinomaChina
-
University College, LondonHoffmann-La RocheNot yet recruiting
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom
-
Changhai HospitalNot yet recruitingHER-2 Protein Overexpression | Esophageal Squamous Carcinoma
-
Christine RyanGenentech, Inc.RecruitingChronic Lymphocytic Leukemia | Richter's TransformationUnited States
-
Hoffmann-La RocheRecruitingLarge B-Cell LymphomaBelgium, Korea, Republic of, Australia, China, Japan, United States, Italy, Spain, Taiwan, United Kingdom, France, Mexico, Poland, Germany, Turkey, Brazil, Argentina, Denmark, Canada